Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

How Do You Solve A Problem Like Sequestration?

Executive Summary

FDA and advocates wait for OMB to clarify how the estimated 7.8% budget cut should be implemented, if it is enacted. Former agency officials say it could lead to hiring freezes and program delays.

You may also be interested in...



FDA’s Hamburg Details Some Sequestration Impacts On FDA

Commissioner says allowing the sequester could slow implementation of some user fee provisions and reduce overseas inspections.

Hamburg Details Some Sequestration Impact On FDA

Commissioner says allowing the sequester would slow implementation of FDASIA provisions and reduce some overseas inspections.

FDA Taking “Risk-Based Approach” To Sequestration Cuts

The agency will try to manage $319 million in potential funding reductions in a way that minimizes negative effects on health and safety, FDA Commissioner Hamburg tells the Science Board, but significant layoffs seem unavoidable if sequestration is enacted.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS054708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel